アレルギー免疫療法の世界市場2016-2020...市場調査レポートについてご紹介

【英文タイトル】Global Allergy Immunotherapies Market 2016-2020

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market Overview
• Assumptions
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Allergies: Overview
• Prevalence of allergic diseases

PART 06: Pipeline analysis

PART 07: Market landscape
• Market overview
• Five forces analysis

PART 08: Market segmentation by product type
• Global SCIT market
• Global SLITD market
• Global SLITT market

PART 09: Geographical segmentation
• Allergy immunotherapies market in Europe
• Allergy immunotherapies market in Germany
• Allergy immunotherapies market in France
• Allergy immunotherapies market in North America
• Allergy immunotherapies market in US
• Allergy immunotherapies market in ROW

PART 10: Market drivers
• Presence of high unmet medical needs
• Existence of novel molecules in pipeline
• Increasing prevalence of allergic rhinitis and asthma coupled with high consumption of tobacco
• Upsurge of allergies due to increase in environmental pollution

PART 11: Impact of drivers

PART 12: Market challenges
• Increased preference for CAM
• Poor patient adherence and high dropout rates
• High cost of allergic immunotherapy

PART 13: Impact of drivers and challenges

PART 14: Market trends
• Emergence of SLITT
• Advent of SPIRE
• Strategic alliances for novel drug developments
• Identification of new allergen targets

PART 15: Vendor landscape
• Competitive scenario
• ALK-Abello
• Stallergenes
• Merck Group
• Allergy Therapeutics
• Other prominent vendors

PART 16: Appendix
• List of abbreviations

PART 17: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Impact of key customer segments 2015
Exhibit 03: Prevalence of HDM allergies in major countries 2015
Exhibit 04: Incidence of allergies 1920-2020 (% of population)
Exhibit 05: Prevalence of allergies in US 2015
Exhibit 06: Prevalence of allergies in Europe 2015
Exhibit 07: Global allergy immunotherapies market: Pipeline portfolio
Exhibit 08: Global allergy immunotherapies market according to drug phase 2015
Exhibit 09: Major pipeline events for allergy immunotherapies 2016-2017
Exhibit 10: Global allergy immunotherapies market snapshot: Developed and emerging markets 2015
Exhibit 11: Growth opportunities for global allergy immunotherapies market
Exhibit 12: Global allergy immunotherapies market 2015-2020 ($ billions)
Exhibit 13: Comparison of active ingredients used in allergy immunotherapy
Exhibit 14: Major healthcare reforms in global allergy immunotherapies market
Exhibit 15: Five forces analysis
Exhibit 16: Global allergy immunotherapy market segmentation by product type 2015
Exhibit 17: Advantages of short-course SCITs
Exhibit 18: Opportunity analysis of global SCIT market
Exhibit 19: Global SCIT market 2015-2020 ($ millions)
Exhibit 20: Opportunity analysis of global SLITD market
Exhibit 21: Global SLITD market 2015-2020 ($ millions)
Exhibit 22: Opportunity analysis of global SLITT market
Exhibit 23: Global SLITT market 2015-2020 ($ millions)
Exhibit 24: Comparison between whole allergen immunotherapies, SCIT, and SLIT
Exhibit 25: Global allergy immunotherapies market segmentation by product type 2015-2020 ($ millions)
Exhibit 26: Global allergy immunotherapies market segmentation by product type 2015-2020
Exhibit 27: Global allergy immunotherapies market: YoY revenue and growth based on product type 2015-2020 ($ millions)
Exhibit 28: Global allergy immunotherapies market: Geography outlook (2015-2020)
Exhibit 29: Revenue and growth outlook in different countries 2015
Exhibit 30: Global allergy immunotherapies market by geographical segmentation 2015
Exhibit 31: Allergy immunotherapies market in Europe 2015-2020 ($ millions)
Exhibit 32: Market share of SLITT and SCIT/SLITD in Europe 2015
Exhibit 33: Market share of allergy immunotherapies in Europe
Exhibit 34: Allergy immunotherapies market in Germany 2015-2020 ($ millions)
Exhibit 35: Allergy immunotherapies market in France 2015-2020 ($ millions)
Exhibit 36: Allergy immunotherapies market in North America 2015-2020 ($ millions)
Exhibit 37: Market share of SLITT and SCIT/SLITD in North America 2015
Exhibit 38: Allery immunotherapies market in North America
Exhibit 39: Market share of allergy immunotherapies in North Americas
Exhibit 40: Allergy immunotherapies market in US 2015-2020 ($ millions)
Exhibit 41: Allergy immunotherapies market in ROW 2015-2020 ($ millions)
Exhibit 42: Global allergy immunotherapies market revenue by geography 2015-2020 ($ millions)
Exhibit 43: Global allergy immunotherapies market revenue by geography 2015-2020
Exhibit 44: Global allergy immunotherapies market: YoY revenue and growth based on geography 2015-2020 ($ millions)
Exhibit 45: Unmet medical needs for severely affected individuals: Key allergens and severe allergic cases
Exhibit 46: Impact of drivers
Exhibit 47: Use of CAM therapies among individuals in US
Exhibit 48: Comparison of different cost components of allergy immunotherapy ($) 2014
Exhibit 49: Impact of drivers and challenges
Exhibit 50: Advantages of SPIRE allergy therapies
Exhibit 51: Market share analysis
Exhibit 52: Market position of top vendors 2015
Exhibit 53: Competitive position of vendors
Exhibit 54: Key vendors: Geographical presence 2015
Exhibit 55: Market share analysis in US
Exhibit 56: Market share analysis in Europe
Exhibit 57: Business segmentation by revenue 2015
Exhibit 58: ALK-Abello: YoY revenue and growth rate of SCIT/SLIT drops 2013-2015 ($ millions)
Exhibit 59: Geographic segmentation of SCIT/SLIT drops 2015
Exhibit 60: ALK-Abello: YoY revenue and growth rate of SLIT tablets 2013-2015 ($ millions)
Exhibit 61: ALK-Abello: Geographic segmentation of SLIT tablets 2015
Exhibit 62: ALK-Abello: Metrics analysis
Exhibit 63: Product categories by revenue
Exhibit 64: Stallergenes: Geographical segmentation by revenue 2015
Exhibit 65: Stallergenes: Metrics analysis
Exhibit 66: Allergopharma: YoY revenue and growth rate of allergy immunotherapy products 2013-2015 ($ millions)
Exhibit 67: Merck Group: Metrics analysis
Exhibit 68: Allergy Therapeutics: YoY revenue and growth rate of key allergy immunotherapies 2013-2015 ($ millions)
Exhibit 69: Allergy Therapeutics: Products by revenue 2015
Exhibit 70: Allergy Therapeutics: Geographical segmentation by revenue 2015
Exhibit 71: Allergy Therapeutics: Metrics analysis


【レポート販売概要】

■ タイトル:アレルギー免疫療法の世界市場2016-2020
■ 英文:Global Allergy Immunotherapies Market 2016-2020
■ 発行日:2016年7月1日
■ 調査会社:Technavio
■ 商品コード:IRTNTR9822
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。